Member access

4-Traders Homepage  >  Shares  >  OTC Bulletin Board  >  IntelGenx Technologies Corp.    IGX   US45822R1014

 SummaryNewsCalendarCompanyFinancialsRevisions 
Company
IntelGenx Technologies Corp. operates as a drug delivery company.It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies.The company is a provider of product development services for the pharmaceutical industry,... 
Sector
Pharmaceuticals
Calendar
04/01Earnings Release
More about the company
Financials ($)
Sales 2011 6,00 M
EBIT 2011 -0,10 M
Net income 2011 -0,10 M
Debt 2011 -
Yield 2011 -
Sales 2012 0,97 M
EBIT 2012 -1,88 M
Net income 2012 -2,14 M
Debt 2012 -
Yield 2012 -
PER 2011 21,28
PER 2012
Capi. / Sales 2011 4,52x
Capi. / Sales 2012 28,1x
Capitalization 27,1 M
More Financials
Latest news on INTELGENX TECHNOLOGIES COR
10h ago INTELGENX TECHNOLOGIES : 2014-11-25 IntelGenx Announces Settlement of U.S. Paten..
13h ago IIROC Trade Halt - IntelGenx Corp.
14h ago IntelGenx Announces Settlement of U.S. Patent Litigation Related to Forfivo X..
11/18 INTELGENX TECHNOLOGIES : 2014-11-18 IntelGenx to Present at Singular Research's ..
11/18 IntelGenx to Present at Singular Research's Best of the Uncovered 2014 NYC Fa..
11/12 INTELGENX TECHNOLOGIES : 2014-11-12 IntelGenx Reports Q3, 2014 Results and Provi..
11/12 IntelGenx Reports Q3, 2014 Results and Provides Corporate Development Update
11/03 INTELGENX TECHNOLOGIES : 2014-11-03 IntelGenx Announces Successful Clinical Stud..
11/03 IntelGenx Announces Successful Clinical Study for Schizophrenia
10/02 INTELGENX TECHNOLOGIES : 2014-10-02 IntelGenx Founder Returns as President and C..
10/02 IntelGenx Founder Returns as President and CEO
10/01 IntelGenx and RedHill Biopharma Submit European Marketing Authorization Appli..
More news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF